ArticleCancer communications (London, England)2020

Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China.

Zongbi Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.